Rezolute CFO Evans Daron Purchases Shares, Company Issues Equity Awards
On December 9, 2025, Evans Daron, Chief Financial Officer of Rezolute, Inc. (NASDAQ:RZLT), acquired 10,549 shares of the company's common stock at a price of $5.04 per share. This transaction increased his total ownership in the biopharmaceutical firm to 131,900 shares.
Separately, Rezolute granted equity inducement awards to two new employees. The awards consist of options to purchase an aggregate of 245,000 shares of common stock.
The options have an exercise price of $9.32 per share and a 10-year term. Vesting occurs over a four-year period, contingent upon the employees' continued service with the company.
Rezolute, which focuses on developing treatments for hypoglycemia, reported a debt-to-equity ratio of 0.0099 and a current ratio of 15.15, indicating low debt reliance and strong short-term liquidity.
Rezolute, Inc. (RZLT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.